He was "interested in all aspects of providing independent, unbiased, clear and concise information about therapeutic interventions to professionals and the public, and [had] a long experience of observing the pharmaceutical industry at work".
[3] Andrew attended the same school where his father worked, and received a bursary as the great nephew of Karl Herxheimer, who identified the inflammatory reaction to antibiotics named after him.
From 1966 to 1973 he served on the British National Formulary Committee and was extraordinary professor of clinical pharmacology in Groningen, the Netherlands, from 1968 to 1977.
"The journal's forthright statements of opinion on the benefit or otherwise of medicines often aroused the irritation of the drug industry, and occasional threats to sue.
"[4] Each article undergoes unusually intense peer review by 20–30 people, including industry, and is published anonymously.
[6] One observer has credited the existence of the National Institute for Health and Care Excellence (NICE) as "[coming] from what the DTB was trying to do".
His wife said "Andrew was so determined to lead a useful life that even when he was in the Royal Free hospital [...] he was handing out leaflets on healthtalk.